Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.65 |
| ▸ | CA2 | P00918 | 3/20 | 0.65 |
| ▸ | CA6 | P23280 | 3/20 | 0.65 |
| ▸ | CA5A | P35218 | 3/20 | 0.65 |
| ▸ | CA7 | P43166 | 3/20 | 0.65 |
| ▸ | CA9 | Q16790 | 3/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.65 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.65 |
| ▸ | CA3 | P07451 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | HPGD | P15428 | 3/20 | 0.65 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | MAOB | P27338 | 7/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | F12 | P00748 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29985431 | 0.91 | KDM4E (0.68) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL29707748 | 0.85 | MAOB (0.72) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL11266285 | 0.85 | MAOA (0.71) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL27080004 | 0.84 | MAOB (0.68) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL11229324 | 0.83 | MAOB (0.60) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL17903545 | 0.82 | MAOB (0.72) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL18589240 | 0.82 | MAOB (0.70) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL31491378 | 0.81 | MAOB (0.71) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL10651297 | 0.81 | KDM4E (0.67) | CA12CA2CA6CA5ACA7 | |
| SCHEMBL22502678 | 0.81 | MEN1 (0.72) | CA12CA2CA6CA5ACA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112607528-B | Control device and method for cable winding motor | 武汉钢铁集团物流有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-218480998-U | Rail brace detection assembly for 60kg/m rail | 湖北武铁山桥轨道装备有限公司 | 2023-02-14 | — | — | CN | claimed |
| EP-3772938-B1 | USE OF A TETRAMIC ACID DERIVATIVE FOR COMBATING ANIMAL DISEASES THROUGH DRIP APPLICATION | BAYER CROPSCIENCE AG (DE) | 2025-08-13 | — | — | EP | disclosed |
| US-20250145509-A1 | Mobile Processing System for Hazardous and Radioactive Isotope Removal | KURION, INC. | 2025-05-08 | — | — | US | disclosed |
| US-12234172-B2 | Mobile processing system for hazardous and radioactive isotope removal | VEOLIA NUCLEAR SOLUTIONS, INC. | 2025-02-25 | — | — | US | disclosed |
| CN-112607528-B | Control device and method for cable winding motor | 武汉钢铁集团物流有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-111270643-B | Heating mechanism for snow melting locking frame of railway turnout | 西安铁路信号有限责任公司 | 2025-02-18 | — | — | CN | disclosed |
| US-12188096-B2 | Clear cell renal cell carcinoma biomarkers | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-01-07 | — | — | US | disclosed |
| EP-4403527-A2 | MOBILE PROCESSING SYSTEM FOR HAZARDOUS AND RADIOACTIVE ISOTOPE REMOVAL | Veolia Nuclear Solutions, Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| CN-111630183-B | Clear cell renal cell carcinoma biomarker | 新加坡科技研究局 | 2024-06-18 | — | — | CN | disclosed |
| US-20230398092-A1 | APPLICATION OF SESQUITERPENE LACTONE COMPOUND IN PREPARATION OF DRUGS FOR ALLEVIATING RADIOTHERAPY-INDUCED INJURIES | ACCENDATECH CO., LTD. (CN) | 2023-12-14 | — | — | US | disclosed |
| US-20230279496-A1 | Clear Cell Renal Cell Carcinoma Biomarkers | SINGAPORE HEALTH SERVICES PTE LTD (SG) | 2023-09-07 | — | — | US | disclosed |
| EP-4233856-A1 | APPLICATION OF SESQUITERPENE LACTONE COMPOUND IN PREPARATION OF DRUGS FOR ALLEVIATING RADIOTHERAPY-INDUCED INJURIES | Accendatech Co. Ltd. (CN) | 2023-08-30 | — | — | EP | disclosed |
| CN-110009608-B | Method for distinguishing rotten blueberries based on low-field nuclear magnetic resonance technology | 沈阳农业大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-218480998-U | Rail brace detection assembly for 60kg/m rail | 湖北武铁山桥轨道装备有限公司 | 2023-02-14 | — | — | CN | disclosed |
| CN-218480998-U | Rail brace detection assembly for 60kg/m rail | 湖北武铁山桥轨道装备有限公司 | 2023-02-14 | — | — | CN | disclosed |
| US-20220339178-A1 | COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF POLLINATORS AGAINST PESTICIDES | COLEGIO MAYOR DE NUESTRA SENORA DEL ROSARIO (CO) | 2022-10-27 | — | — | US | disclosed |
| US-20220289609-A1 | Mobile Processing System for Hazardous and Radioactive Isotope Removal | VEOLIA NUCLEAR SOLUTIONS, INC. | 2022-09-15 | — | — | US | disclosed |
| CN-217387970-U | Low pressure distribution panel support frame | 深圳市恒通电力设备有限公司 | 2022-09-06 | — | — | CN | disclosed |
| EP-3988181-A1 | MOBILE PROCESSING SYSTEM FOR HAZARDOUS AND RADIOACTIVE ISOTOPE REMOVAL | Veolia Nuclear Solutions, Inc. (US) | 2022-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220339178-A1 | COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF POLLINATORS AGAINST PESTICIDES | ACHE, BCHE, GAP43 | CA12 2974/4885CA2 701/4885CA6 2167/4885 |
| US-20230398092-A1 | APPLICATION OF SESQUITERPENE LACTONE COMPOUND IN PREPARATION OF DRUGS FOR ALLEVIATING RADIOTHERAPY-INDUCED INJURIES | TP53, VIP, SI | CA12 280/4885CA2 2986/4885CA6 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.